Morgan LR - Search Results

1

Comparative preclinical toxicology and pharmacology of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) in vitro and in rodents and primates.

Morgan LR, Rodgers AH, Fan D, Soike K, Ratterree M, Sartin BW, Harrison TJ. Morgan LR, et al. In Vivo. 1997 Jan-Feb;11(1):29-37. In Vivo. 1997. PMID: 9067770

2

Design, synthesis, and anticancer properties of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone and analogues.

Morgan LR, Thangaraj K, LeBlanc B, Rodgers A, Wolford LT, Hooper CL, Fan D, Jursic BS. Morgan LR, et al. J Med Chem. 2003 Oct 9;46(21):4552-63. doi: 10.1021/jm0301080. J Med Chem. 2003. PMID: 14521417

3

Relative bioavailability of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) in rats and monkeys.

Subramasnian S, Rodgers AH, Morgan LR, Soike K, Ratteree M. Subramasnian S, et al. Among authors: morgan lr. J Exp Ther Oncol. 1996 Jan;1(1):62-5. J Exp Ther Oncol. 1996. PMID: 9414389

4

Anticancer properties for 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007)/3,7-diaminophenothiazin-5-ium double salts.

Morgan LR, Rodgers AH, LeBlanc BW, Boué SM, Yang Y, Jursic BS, Cole RB. Morgan LR, et al. Bioorg Med Chem Lett. 2001 Aug 20;11(16):2193-5. doi: 10.1016/s0960-894x(01)00408-5. Bioorg Med Chem Lett. 2001. PMID: 11514168

5

Comparative dermal pharmacology and toxicology of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) in rodents and primates.

Morgan LR, Rodgers AH, Hooper CL, Ratterree M, Soike K, Serota D, Beis R, Schwartz SL. Morgan LR, et al. In Vivo. 2001 Nov-Dec;15(6):479-84. In Vivo. 2001. PMID: 11887332

6

High-performance liquid chromatographic determination of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone in plasma.

Rodgers AH, Subramanian S, Morgan LR Jr. Rodgers AH, et al. Among authors: morgan lr jr. J Chromatogr B Biomed Appl. 1995 Aug 18;670(2):365-8. doi: 10.1016/0378-4347(95)00164-6. J Chromatogr B Biomed Appl. 1995. PMID: 8548030

7

Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide.

Germann N, Urien S, Rodgers AH, Ratterree M, Struck RF, Waud WR, Serota DG, Bastian G, Jursic BS, Morgan LR. Germann N, et al. Among authors: morgan lr. Cancer Chemother Pharmacol. 2005 Feb;55(2):143-51. doi: 10.1007/s00280-004-0894-y. Epub 2004 Sep 14. Cancer Chemother Pharmacol. 2005. PMID: 15592722

8

4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers.

Eilender D, LoRusso P, Thomas L, McCormick C, Rodgers AH, Hooper CL, Tornyos K, Krementz ET, Parker S, Morgan LR. Eilender D, et al. Among authors: morgan lr. Cancer Chemother Pharmacol. 2006 Jun;57(6):719-26. doi: 10.1007/s00280-005-0124-2. Epub 2005 Sep 24. Cancer Chemother Pharmacol. 2006. PMID: 16184382 Clinical Trial.

9

Adoptive immunotherapy of advanced renal cell cancer using PHA-stimulated autologous lymphocytes.

Morgan LR, Krementz ET, Fan SW, Fan D. Morgan LR, et al. Anticancer Res. 1993 Sep-Oct;13(5C):1763-7. Anticancer Res. 1993. PMID: 8267379 Clinical Trial.

10

Anticancer activity for 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) analogues and their abilities to interact with lymphoendothelial cell surface markers.

Morgan LR, Jursic BS, Hooper CL, Neumann DM, Thangaraj K, LeBlanc B. Morgan LR, et al. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3407-11. doi: 10.1016/s0960-894x(02)00725-4. Bioorg Med Chem Lett. 2002. PMID: 12419372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters